NO941358L - Vandig farmasöytisk suspensjon og fremgangsmåte for fremstilling derav - Google Patents

Vandig farmasöytisk suspensjon og fremgangsmåte for fremstilling derav

Info

Publication number
NO941358L
NO941358L NO941358A NO941358A NO941358L NO 941358 L NO941358 L NO 941358L NO 941358 A NO941358 A NO 941358A NO 941358 A NO941358 A NO 941358A NO 941358 L NO941358 L NO 941358L
Authority
NO
Norway
Prior art keywords
suspension
aqueous pharmaceutical
preparation
carboxymethyl cellulose
pharmaceutical suspension
Prior art date
Application number
NO941358A
Other languages
English (en)
Norwegian (no)
Other versions
NO941358D0 (no
Inventor
Sheila M Ratnaraj
Warren L Sunshine
Original Assignee
Mcneil Ppc Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mcneil Ppc Inc filed Critical Mcneil Ppc Inc
Publication of NO941358D0 publication Critical patent/NO941358D0/no
Publication of NO941358L publication Critical patent/NO941358L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO941358A 1993-04-16 1994-04-15 Vandig farmasöytisk suspensjon og fremgangsmåte for fremstilling derav NO941358L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4870193A 1993-04-16 1993-04-16

Publications (2)

Publication Number Publication Date
NO941358D0 NO941358D0 (no) 1994-04-15
NO941358L true NO941358L (no) 1994-10-17

Family

ID=21955969

Family Applications (1)

Application Number Title Priority Date Filing Date
NO941358A NO941358L (no) 1993-04-16 1994-04-15 Vandig farmasöytisk suspensjon og fremgangsmåte for fremstilling derav

Country Status (5)

Country Link
US (1) US5658919A (de)
EP (1) EP0620001A1 (de)
CA (1) CA2121435C (de)
FI (1) FI941777A7 (de)
NO (1) NO941358L (de)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5534552A (en) * 1994-03-02 1996-07-09 Warner-Lambert Company Clear non-alcoholic sinus and allergy medication
CN1132070A (zh) * 1994-12-21 1996-10-02 麦克尼尔-Ppc公司 药用的水悬浮液制剂
US5563177A (en) * 1995-01-30 1996-10-08 American Home Products Corporation Taste masking guaifenesin containing liquids
NZ272574A (en) * 1995-07-14 1999-02-25 Lilly Eli & Co Nz Ltd Aqueous base suspension concentrate containing at least one ionophore antibiotic and wetting agent and/or a surfactant and xanthan gum optionally with a suspension agent, an antifreeze agent and an antifoaming agent; drench for veterinary treatment
AU774516C (en) * 1995-07-14 2005-12-22 Eli Lilly & Co (Nz) Limited Ionophore antibiotic formulations
WO1997003650A1 (en) * 1995-07-14 1997-02-06 Eli Lilly & Company (Nz) Limited Ionophore antibiotic formulations
NZ280384A (en) 1995-11-02 1997-01-29 Lilly Eli & Co Nz Ltd Animal feed supplement comprising a wettable powder composition of an ionophore antibiotic
FR2751875B1 (fr) * 1996-08-05 1998-12-24 Scr Newpharm Nouvelles formulations liquides stables a base de paracetamol et leur mode de preparation
US6132758A (en) * 1998-06-01 2000-10-17 Schering Corporation Stabilized antihistamine syrup
USH2044H1 (en) 1998-11-02 2002-09-03 Mcneil-Ppc, Inc. Container with retaining member
AU2002220248A1 (en) * 2000-11-06 2002-05-15 Andrx Pharmaceuticals, Inc. Once a day antihistamine and decongestant formulation
WO2002072102A1 (en) * 2001-03-05 2002-09-19 Ortho-Mcneil Pharmaceutical, Inc. Taste masked liquid pharmaceutical compositions
WO2003011306A1 (en) * 2001-07-31 2003-02-13 Wyeth Sucralose formulations to mask unpleasant tastes
US7101572B2 (en) * 2001-12-07 2006-09-05 Unilab Pharmatech, Ltd. Taste masked aqueous liquid pharmaceutical composition
CN1582170B (zh) * 2001-12-18 2010-05-05 联合制药克伦茨蒂斯药物实验室公司 扑热息痛的肠胃外组合物
US6602490B1 (en) * 2002-03-04 2003-08-05 Richard A. Cloonan Dental cleaning formulation and manufacturing process
US7049435B2 (en) 2002-03-08 2006-05-23 Tate & Lyle Public Limited Company Extractive methods for purifying sucralose
US6998480B2 (en) 2002-03-08 2006-02-14 Tate & Lyle Public Limited Company Process for improving sucralose purity and yield
US7300670B2 (en) 2002-04-03 2007-11-27 Unilab Pharmatech, Ltd. Oral suspension formulation
GB2389530B (en) * 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
US20040101563A1 (en) * 2002-07-18 2004-05-27 Kundu Subhas C. Storage stable antihistaminic syrup formulations
EP1546120A4 (de) * 2002-10-04 2006-11-22 Pharmacia Corp Pharmazeutische zusammensetzung zur behandlung von parkinson-krankheit
US8092831B2 (en) * 2002-11-08 2012-01-10 Andrx Pharmaceuticals, Llc Antihistamine and decongestant system
US20040170686A1 (en) * 2003-01-31 2004-09-02 Fredrickson Jennifer K. Suspension vehicle for coated drug particles
US20040191326A1 (en) * 2003-03-31 2004-09-30 Reo Joseph P. Taste-masking vehicle for coated oxazolidinone particles
US20050069590A1 (en) * 2003-09-30 2005-03-31 Buehler Gail K. Stable suspensions for medicinal dosages
US20050095299A1 (en) * 2003-10-30 2005-05-05 Wynn David W. Controlled release analgesic suspensions
US20050095300A1 (en) * 2003-10-30 2005-05-05 Wynn David W. Controlled release analgesic suspensions
US20050266031A1 (en) * 2004-05-25 2005-12-01 Jay Dickerson Pharmaceutical suspension composition
US20060062811A1 (en) * 2004-09-21 2006-03-23 Szymczak Christopher E Medicinal cooling emulsions
US20060093629A1 (en) * 2004-10-29 2006-05-04 Buehler Gail K Dye-free pharmaceutical suspensions and related methods
US20060093631A1 (en) * 2004-10-29 2006-05-04 Buehler Gail K Dye-free pharmaceutical suspensions and related methods
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
US8758816B2 (en) 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
DK2486942T3 (en) 2004-11-24 2019-01-28 Meda Pharmaceuticals Inc COMPOSITIONS CONTAINING AZELASTINE AND PROCEDURES FOR USING IT
US20070026026A1 (en) * 2005-08-01 2007-02-01 David Delmarre Oral liquid losartan compositions
GB2438287A (en) * 2006-05-19 2007-11-21 Norbrook Lab Ltd Stable aqueous suspension
US20080014275A1 (en) * 2006-07-13 2008-01-17 Buehler Gail K Pharmaceutical suspensions and related methods
CA2681545C (en) 2007-03-28 2013-10-01 Apotex Technologies Inc. Fluorinated derivatives of deferiprone
WO2009067605A2 (en) * 2007-11-21 2009-05-28 The Procter & Gamble Company Preparations, methods and kits useful for treatment of cough
US8436156B2 (en) * 2008-01-04 2013-05-07 Tate & Lyle Technology Limited Method for the production of sucralose
US8362083B2 (en) * 2008-01-15 2013-01-29 C.B. Fleet Company Inc. Taste-masked docusate compositions
EP2254677A1 (de) * 2008-03-20 2010-12-01 Tate & Lyle Technology Limited Entfernung von säuren aus tertiäramid-lösungsmitteln
US8436157B2 (en) * 2008-03-26 2013-05-07 Tate & Lyle Technology Limited Method for the production of sucralose
US8497367B2 (en) * 2008-04-03 2013-07-30 Tate & Lyle Technology Limited Sucralose purification process
WO2009124113A1 (en) * 2008-04-03 2009-10-08 Tate & Lyle Technology Ltd. Extraction of less polar impurities from sucralose containing aqueous feed streams
AR071134A1 (es) * 2008-04-03 2010-05-26 Tate & Lyle Technology Ltd Cristalizacion de sucralosa a partir de chorros que contienen sucralosa
KR20100127875A (ko) * 2008-04-03 2010-12-06 테이트 앤드 라일 테크놀러지 리미티드 수크랄로오스 추출 효율에 대한 탄수화물 농도의 효과
PL2268282T3 (pl) * 2008-04-25 2015-04-30 Apotex Tech Inc Płynny preparat deferypronu o przyjemnym smaku
GB2469158B (en) 2009-03-31 2011-09-28 Peter J Seaberg Base-assisted formation of tin-sucrose adducts
ME01911B (me) 2009-07-03 2014-12-20 Apotex Tech Inc Fluorisani derivati 3-hidroksipiridin-4-ona
GB2474310B (en) 2009-10-12 2012-02-29 Tate & Lyle Technology Ltd Process for the production of sucrose-6-ester
GB2474311B (en) * 2009-10-12 2012-10-17 Tate & Lyle Technology Ltd Low temperature, single solvent process for the production of sucrose-6-ester
EP2691080A1 (de) * 2011-03-31 2014-02-05 McNeill-PPC, Inc. Zusammensetzung von mentholflüssigkeiten
GB201110520D0 (en) 2011-05-10 2011-08-03 Tate & Lyle Technology Ltd Extraction of carboxylic acids with tin compounds
EP3061501A1 (de) 2015-02-27 2016-08-31 Rottapharm Ltd. Zusammensetzung zur behandlung von akne
EP3117825A1 (de) 2015-07-16 2017-01-18 Rottapharm S.p.A. Orale formulierung mit berberin und morus-alba-extrakt
CN109906079B (zh) * 2016-06-16 2022-09-30 库蒂斯制药公司 用于质子泵抑制剂混悬剂的组合物和方法
US11234897B2 (en) 2017-03-27 2022-02-01 DXM Pharmaceutical, Inc. Packaged multi-dose liquid dextromethorphan hydrobromide formulation
JP7249670B2 (ja) * 2017-10-03 2023-03-31 ネヴァカー インジェクテーブルズ インコーポレイテッド アセトアミノフェン－プレガバリン組み合わせ及び疼痛を処置する方法
GR1009462B (el) * 2017-10-05 2019-02-15 Laboserve Φαρμακευτικη Βιομηχανια Α.Ε. Ποσιμο φαρμακευτικο διαλυμα με συγκαλυμμενη γευση
AU2019328411B2 (en) 2018-08-28 2022-02-10 Gsk Consumer Healthcare Sarl Paracetamol liquid suspensions
KR20200053746A (ko) 2018-11-09 2020-05-19 (주)아모레퍼시픽 졸-겔 조성물
US10751333B1 (en) 2019-07-16 2020-08-25 Cutispharma, Inc. Compositions and kits for omeprazole suspension
US11633478B2 (en) 2019-07-16 2023-04-25 Azurity Pharmaceuticals, Inc. Compositions and kits for Omeprazole suspension
CN112274483A (zh) * 2020-10-28 2021-01-29 河北冀衡药业股份有限公司 一种对乙酰氨基酚混悬滴剂及其制备方法
CN112587483A (zh) * 2020-12-16 2021-04-02 上海应用技术大学 一种具有掩味效果的小儿复方感冒干混悬剂及其制备方法和应用
CN118845504B (zh) * 2024-06-25 2025-08-22 广州汇创化妆品有限公司 一种悬浮增稠组合物及应用
WO2026015616A1 (en) 2024-07-09 2026-01-15 Drotastar Llc Stable and palatable oral solutions of drotaverine and method of preparation thereof

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3539365A (en) * 1967-02-13 1970-11-10 Fmc Corp Dispersing and stabilizing agent comprising beta-1,4 glucan and cmc and method for its preparation
US4145440A (en) * 1977-08-18 1979-03-20 The Upjohn Company Liquid suspension of an aluminum salt of ibuprofen
US4361580A (en) * 1980-06-20 1982-11-30 The Upjohn Manufacturing Company Aluminum ibuprofen pharmaceutical suspensions
US4327076A (en) * 1980-11-17 1982-04-27 Life Savers, Inc. Compressed chewable antacid tablet and method for forming same
US4923981A (en) * 1982-09-03 1990-05-08 Sbp, Inc. Use of parenchymal cell cellulose to improve comestibles
US4427681A (en) * 1982-09-16 1984-01-24 Richardson-Vicks, Inc. Thixotropic compositions easily convertible to pourable liquids
US5173305A (en) * 1985-03-06 1992-12-22 Grimberg Georges Serge Composition for protection of oesogastroduodenal mucous membrane
IT1183574B (it) * 1985-05-08 1987-10-22 Eurand Spa Metodo per ottenere una sospensione estemporanea omogenea di microcapsule
US4857324A (en) * 1985-10-08 1989-08-15 American Home Products Corporation (Del.) Exogenously acidified antacid compositions having cytoprotective properties
US4711774A (en) * 1986-03-27 1987-12-08 Warner-Lambert Company Medicament adsorbates with complex magnesium aluminum silicate and their preparation
US4716033A (en) * 1986-03-27 1987-12-29 Warner-Lambert Company Medicament adsorbates with surfactant and their preparation
US4761274A (en) * 1986-03-27 1988-08-02 Warner-Lambert Company Medicament adsorbates of analgesics with complex magnesium aluminum silicate and their preparation
US4717565A (en) * 1986-03-27 1988-01-05 Warner-Lambert Company Process for the preparation of medicament adsorbates
GB8618847D0 (en) * 1986-08-01 1986-09-10 Smith Kline French Lab Pharmaceutical formulations
US4895723A (en) * 1986-09-08 1990-01-23 Amer And Company Cholestyramine compositions and method for preparation thereof
CA1287627C (en) * 1986-11-21 1991-08-13 Arthur P.G. Wright Essentially pure polyalcohol aluminum complexes and their preparation
US4882324A (en) * 1986-11-21 1989-11-21 Wright Arthur P G Essentially pure acid hydroxyl ligand aluminum complexes and their preparation
US4772724A (en) * 1986-12-02 1988-09-20 Warner-Lambert Canada Inc. Essentially pure acid hydroxyl ligand aluminum complexes and their preparation
CA1276022C (en) * 1986-11-21 1990-11-06 Arthur P. G. Wright Essentially pure acidic amine ligand aluminum complexes and their preparation
GB8628359D0 (en) * 1986-11-27 1986-12-31 Zyma Sa Galenical formulation
US4788220A (en) * 1987-07-08 1988-11-29 American Home Products Corporation (Del.) Pediatric ibuprofen compositions
IL90245A (en) * 1988-05-11 1994-04-12 Glaxo Group Ltd Resin adsorbate comprising ranitidine together with a synthetic cation exchange resin, its preparation and pharmaceutical compositions containing it
US4975465A (en) * 1989-03-28 1990-12-04 American Home Products Corporation Orally administrable ibuprofen compositions
NZ234143A (en) * 1989-06-28 1991-10-25 Mcneil Ppc Inc Aqueous pharmaceutical suspension formulation for administering substantially insoluble pharmaceutical agents
US5112604A (en) * 1989-09-01 1992-05-12 Riker Laboratories, Inc. Oral suspension formulation
US5013557A (en) * 1989-10-03 1991-05-07 Warner-Lambert Company Taste masking compositions comprising spray dried microcapsules containing sucralfate and methods for preparing same
US5024997A (en) * 1990-06-22 1991-06-18 American Home Products Corporation Palatable ibuprofen solutions
US5196436A (en) * 1990-10-31 1993-03-23 The Procter & Gamble Company Dextromethorphan antitussive compositions
US5107842A (en) * 1991-02-22 1992-04-28 Molecular Biosystems, Inc. Method of ultrasound imaging of the gastrointestinal tract
US5205290A (en) * 1991-04-05 1993-04-27 Unger Evan C Low density microspheres and their use as contrast agents for computed tomography
US5272137A (en) * 1992-02-14 1993-12-21 Mcneil-Pfc, Inc. Aqueous pharmaceutical suspension for pharmaceutical actives
US5167964A (en) * 1992-02-14 1992-12-01 Warner-Lambert Company Semi-enteric drug delivery systems and methods for preparing same

Also Published As

Publication number Publication date
FI941777L (fi) 1994-10-17
CA2121435A1 (en) 1994-10-17
US5658919A (en) 1997-08-19
FI941777A7 (fi) 1994-10-17
CA2121435C (en) 2002-01-22
EP0620001A1 (de) 1994-10-19
FI941777A0 (fi) 1994-04-15
NO941358D0 (no) 1994-04-15

Similar Documents

Publication Publication Date Title
CA2121435A1 (en) Aqueous pharmaceutical suspension and process for preparation thereof
AR002976A1 (es) Formulaciones farmaceuticas parenterales de efecto prolongado de insulina; cristales de dichos analogos aplicables en dichas formulaciones yprocedimiento de las formulaciones mencionadas
CA2019863A1 (en) Aqueous pharmaceutical suspension for substantially water insoluble pharmaceutical actives
DK0865281T3 (da) Naphthylsubstituerede benzimidazolderivater som antikoagulerende midler
ES8802053A1 (es) Un procedimiento para la preparacion de nuevas piranopiridinas
DK0894084T3 (da) Kanelsyrederivater og deres anvendelse som integrinantagonister
NO863823D0 (no) 1,5-benzothiazepinderivater som er anvendelige som utgangsmaterialer ved fremstilling av nye, terapeutisk aktive 8-klor-1,5-benzothiazepinderivater, og fremgangsmaate ved deres fremstilling.
CA1258859A (en) CARBOSTYRILE DERIVATIVE, AND ITS PREPARATION
BG101106A (en) Medicamentous forms of risperidon in aqueous solution
CA2217006A1 (en) Novel substituted piperazine derivatives having tachykinin receptor antagonists activity
ES8504183A1 (es) Un nuevo procedimiento para la preparacion de nuevos cromanos y cromenos.
NO964871L (no) Nye agonistforbindelser
CA2354057A1 (en) Sustained release tablet containing hydrocolloid and cellulose ether
AU6930591A (en) Method for inhibiting aging
IL96636A0 (en) Piperidine derivatives and pharmaceutical compositions containing them
GR1003658B (el) Δισκιο μητρας που καθιστα δυνατη την παρατεταμενη απελευθερωση της τριμεταζιδινης μετα χορηγηση δια της στοματικης οδου
DK157785D0 (da) 1,5-benzothiazepinderivater og fremgangsmaade til deres fremstilling
NO20000722L (no) 2-(4-aryl eller heteroaryl-piperazin-1-ylmetyl)-1H- indolderivater
NO932054L (no) Fremgangsmaate for fremstilling av en fast enhetsdoseringsform med regulert frigjoeringseffekt
AU5714286A (en) Quinolylglycinamide derivatives,the process for preparation thereof and their therapeutic application as psychotropic drugs
NO931905L (no) 8-en-19, 11beta-broede steroider, deres fremstilling og farmasoeytiske preparater inneholdende disse
NO20045132L (no) Benzo(c)kinolizinderivater, deres fremstilling og anvendelse som 5alfa- reduktaseinhibitorer
DE3567651D1 (en) Novel 1,5-benzothiazepine derivative, processes for preparing the same and pharmaceutical compositions
NO980058L (no) Opthalmiske preparater
NO864635L (no) Nye krystallinske salter av aryloksypropanolaminer, deres fremstilling og anvendelse.